Showing 526-538 of 538
-
Altered expression and activity of phase I and II biotransformation enzymes in human liver cells by perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS)
Science
10 Dec 2019 | Toxicology
PFOA and PFOS found to inhibit the body's ability to breakdown and absorb nutrients.
-
Topic of Cancer: How PFAS threaten our water
News
10 Dec 2019 | Capital & Main
What’s more, while the persistent and mobile nature of PFAS chemicals means that no neighborhood is safe from contamination, smaller water systems—particularly those serving disadvantaged communities—face an uphill task in tackling the problem due to the higher probability of aging infrastructure and limited resources, as compared to larger utilities.
-
Top U.S. toxicologist was barred from saying PFAS cause disease in humans. She’s saying it now
News
24 Oct 2019 | The Intercept
“I was banned from doing it,” said Birnbaum. “I had to use ‘association’ all the time. If I was talking about human data or impacts on people, I had to always say there was an association with a laundry list of effects.”
-
Temporal Trends (1981-2013) of per- and polyfluoroalkyl substances and total fluorine in Baltic cod (Gadus morhua)
Science
22 Oct 2019 | Environ. Toxicol. Chem.
Decrease body length was associated with PFDoDA and FOSA exposure.
-
Perfluoroalkyl substances and bone health in young men: a pilot study.
Science
8 Oct 2019 | Endocrine
Exposure to PFAS may lead to an increased risk of developing osteoporosis.
-
Association between perfluoroalkyl substance exposure and thyroid hormone/thyroid antibody levels in maternal and cord blood: The Hokkaido Study
Science
16 Sep 2019 | Environ Int
Hormone function disrupted by the presence of PFAS in a cohort of 701 mother‑neonate pairs.
-
Human-Based Exposure Levels of Perfluoroalkyl Acids May Induce Harmful Effects to Health by Disrupting Major Components Androgen Receptor Signalling In Vitro
Science
27 Aug 2019 | Exp. & Health
Certain PFAS found to disrupt multiple parts of the human endocrine system.
-
Maternal Plasma per- and Polyfluoroalkyl Substance Concentrations in Early Pregnancy and Maternal and Neonatal Thyroid Function in a Prospective Birth Cohort: Project Viva (USA)
Science
8 Jul 2019 | Environmental Health Perspectives
Prenatal exposure to PFAS negatively influences thyroid function in both mothers and infants.
-
Accumulation, Biotransformation, and Endocrine Disruption Effects of Fluorotelomer Surfactant Mixtures on Zebrafish
Science
28 Jun 2019 | Chem. Res. Toxicol.
Alternatives to PFOS shown to disrupt the endocrine system and impair offspring development in zebrafish, a human model organism.
-
Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study
Science
28 Jun 2019 | Int J Hyg Environ Health
Exposure to PFOA linked to reduced lung function in young children.
-
Perfluoroalkyl and polyfluoroalkyl substances and fetal thyroid hormone levels in umbilical cord blood among newborns by prelabor caesarean delivery
Science
19 Jun 2019 | Environ Int
Prenatal exposure to certain PFAS disrupts fetal thyroid function.
-
Exposure to perfluoroalkyl substances (PFAS) and associations with thyroid parameters in First Nation children and youth from Quebec
Science
24 Apr 2019 | Environ Int
PFAS exposure in Canadian indigenous communities children linked to endocrine disruption.
-
Airway exposure to perfluorooctanoate exacerbates airway hyperresponsiveness and downregulates glucocorticoid receptor expression in asthmatic mice.
Science
16 Mar 1921 | Transl Pediatr
Acute airway exposure to PFOA was found to decrease the effectiveness of asthma treatments.